COMMUNIQUÉS West-GlobeNewswire

Crawford Healthcare Inc. Receives New Innovative Technology Contract from Vizient, Inc. for Touchless Care Zinc Protectant Spray

01/02/2018 - 21:46

DOYLESTOWN, Pa. and CHESHIRE, United Kingdom, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Crawford Healthcare announced its Touchless Care Zinc Protectant Spray has received an Innovative Technology contract from Vizient, Inc . [...]

Alpha Pro Tech, Infection Control Segment, N-95 Facemask Product Availability Update Seasonal Influenza

01/02/2018 - 20:00

Nogales, Ariz., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

CROSSJECT : La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin

01/02/2018 - 19:42

Communiqué de Presse La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin Dijon, le 1 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

HempAmericana Announces Interview Ahead of Full-Scale CBD Oil Production Activity

01/02/2018 - 18:23

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce a new interview with Company CEO, Salvador Rosillo, from Uptick [...]

Insider tradings

01/02/2018 - 17:47

Nasdaq Copenhagen 1 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]

NICOX : Number of voting rights as of January 31, 2018

01/02/2018 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,459,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On February 1, 2018, MONTHLY PUBLICATION OF THE [...]

NICOX : Nombre de droits de vote au 31 janvier 2018

01/02/2018 - 17:45

Nicox SA Société anonyme au capital de 29 459 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er février 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]

New Chief Human Resources Officer Joins Corizon Health

01/02/2018 - 16:50

BRENTWOOD, Tenn., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Carolyn Schneider has joined Corizon Health as its Chief Human Resources Officer, CEO Steve Rector announced. “Carolyn’s extensive experience in integrating workforces [...]

Alder BioPharmaceuticals, Inc. Announces Closing of $250 Million of 2.50% Convertible Senior Notes Due 2025

01/02/2018 - 16:46

BOTHELL, Wash., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]

Insider tradings

01/02/2018 - 16:32

Nasdaq Copenhagen 1 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]

Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis

01/02/2018 - 15:46

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction

01/02/2018 - 15:32

LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]

Wildflower Closes on $2 Million Private Placement to Meet Massive California Demand

01/02/2018 - 15:05

VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the " Company ") is pleased to announce a private placement of units (“ Units ”) at a price of C$1.50 per Unit for [...]

Shire plc : Notice of Results

01/02/2018 - 15:01

Shire to announce full year 2017 results Dublin, Ireland - February 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce full year 2017 earnings on Wednesday February 14, 2018. Results press release will be [...]

Nuvectra™ Announces Pricing of Follow-On Stock Offering

01/02/2018 - 15:00

PLANO, Texas, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 [...]

Predictive Technology Group, Inc. (PRED) Appoints Ronald Barhorst to Chair Its Financial Advisory Board

01/02/2018 - 15:00

SALT LAKE CITY, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]

INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors

01/02/2018 - 15:00

PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain

01/02/2018 - 14:43

VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into an investment agreement (the “ [...]

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

01/02/2018 - 14:30

Data Demonstrate AFM13 in Combination with Keytruda® (Pembrolizumab) Doubled Complete Response Rate in Hodgkin Lymphoma Patients Early Data Suggest New Opportunity for AFM13 in CD30-positive Lymphoma AFM13 is Clinically [...]